Observational study of pathology, treatment and prognosis of IgA nephropathy

Observational study of pathology, treatment and prognosis of IgA nephropathy - Observational study of pathology, treatment and prognosis of IgA nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044262

Enrollment

500

Registered

2026-04-01

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with IgA nephropathy and treated

Exclusion criteria

Exclusion criteria: Patients who refused by Opt-out

Design outcomes

Primary

Measure	Time frame
Remission rate, recurrence rate or renal survival rate, renal function decline rate (annual eGFR decline rate)	—

Secondary

Measure	Time frame
Adverse side effect	—

Countries

Japan

Contacts

Public ContactTatsuo Tsukamoto

Kitano Hospital, Tazuke Kofukai Medical Research Institute Department of Nephrology & Dialysis

tsukamoto5017@gmail.com66312122

Outcome results